Based on this, NRF2 inducers, already proposed as FRDA therapeutics53,54,60 could be also advantageous for preserving BAT integrity and mitigating metabolic disturbances of FRDA patients via a BAT-dependent manner. Here, NFE2L2 is linked to Friedreich ataxia.